InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by Myers C. Daniel. Officer active across 2 companies, notably Kala Pharmaceuticals, Inc.. Cumulatively, 4 reports have been published. History available since 22 June 2023. The latest transaction was filed on 15 June 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Myers C. Daniel is a declarant linked to KALA BIO, Inc. and Kala Pharmaceuticals, Inc., where he is a director. He has 4 filings in total, and in the sampled recent filings the transaction nature is attribution, with dates ranging from 2023-06-02 to 2025-06-17 and buy and sell amounts of EUR 0.